| Pharmaceutical Information |
| Drug Name |
Metipranolol |
| Drug ID |
BADD_D01441 |
| Description |
A beta-adrenergic antagonist effective for both beta-1 and beta-2 receptors. It is used as an antiarrhythmic, antihypertensive, and antiglaucoma agent. |
| Indications and Usage |
Indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open angle glaucoma. |
| Marketing Status |
Prescription |
| ATC Code |
S01ED04 |
| DrugBank ID |
DB01214
|
| KEGG ID |
D02374
|
| MeSH ID |
D014290
|
| PubChem ID |
31477
|
| TTD Drug ID |
D0L5FY
|
| NDC Product Code |
Not Available |
| Synonyms |
Metipranolol | Methypranol | Trimepranol | 1-(4-Acetoxy-2,3,5-Trimethylphenoxy)-3-Isopropylamino-2-Propanol | Disorat |
|
| Chemical Information |
| Molecular Formula |
C17H27NO4 |
| CAS Registry Number |
22664-55-7 |
| SMILES |
CC1=CC(=C(C(=C1OC(=O)C)C)C)OCC(CNC(C)C)O |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
